Gilead Sciences
Price & Volume
Stats
See more52W Range | $111.27-$154.51 |
Market Cap | $187.4B |
Shares Short | 21M |
Financials
See moreRevenue (12 Mos) | $30.4B |
Revenue Growth (YoY) | 10.2% |
Gross Profit (12 Mos) | $24.2B |
Diluted EPS | -$2.65 |
News
See moreYahoo Finance • yesterday
Gilead Has Outperformed the S&P 500. But is its Valuation Still Attractive?
Yahoo Finance • 5 days ago
Is Extending the Gilead E3 Ligase Collaboration Altering The Investment Case For Nurix Therapeutics (NRIX)?
Yahoo Finance • 5 days ago
Is Abbott Laboratories (ABT) a Dividend Bargain After Its 2026 Selloff?
Yahoo Finance • 5 days ago
U.S. equities tumble while Treasury yields push higher
About
CEO | Mr. Daniel Patrick O'Day |
CFO | Mr. Andrew D. Dickinson |
Address | 333 Lakeside Drive, Foster City, CA, United States, 94404 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 17,000 |